DELIVERY ORDER
ExpiredSPE2DP26F6513
Department of Defense › Defense Logistics Agency › DLA TROOP SUPPORT
$1.2M
obligated · signed 4 months ago
8512183379!ADENOVIRUS TYPE 4 A
Performance timeline
Start
Jun 16, 2026
End
Jun 23, 2026
with all options
Loading status
This contract has expired. A follow-on may have been awarded.
Search for new solicitations from Department of Defense.
TEVA PHARMACEUTICALS USA, INC.
Contract SPE2DP26F6513
UEI
NEN9A34LRHJ5
Parent Company
TEVA PHARMACEUTICALS USA, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$1,202,342
Base + Exercised Options
$1,202,342
Total Ceiling Value
$1,202,342
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 11
Awarding Agency
Funding Agency
Contract Vehicle
SPE2DP20D0002
IDCDepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.